Uncontrolled reactivation of EBV infection in a 26-year-old woman

This report describes the case of a 26-year-old woman, who was admitted to oncological centre with symptoms of lymphoma, but final diagnosis indicated CAEBV virus infection. The patient had never been treated for chronic diseases before, and lymphoma was suspected due to: clinical symptoms (neck lymphadenopathy, febrile conditions), and imaging and endoscopic ultrasound examinations (CT, EUS). During the examinations in the oncological centre, lymphoma diagnosis was turned down and CAEBV infection was recognised. Despite the treatment applied in accordance with global standards, the patient developed multi-organ failure, which led to her death.

[1]  K. Peck,et al.  An Adult Case of Chronic Active Epstein-Barr Virus Infection with Interstitial Pneumonitis , 2011, The Korean journal of internal medicine.

[2]  H. Einsele,et al.  Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia , 2009, Bone Marrow Transplantation.

[3]  H. Kimura Pathogenesis of chronic active Epstein‐Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? , 2006, Reviews in medical virology.

[4]  H. Kanegane,et al.  Proposed guidelines for diagnosing chronic active Epstein‐Barr virus infection , 2005, American journal of hematology.

[5]  H. Kanegane,et al.  Prognostic factors for chronic active Epstein-Barr virus infection. , 2003, The Journal of infectious diseases.

[6]  H. Kanegane,et al.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. , 2001, Blood.

[7]  J. Cohen Epstein-Barr Virus Infection , 2000 .

[8]  K. Hirai,et al.  Clonal lymphoproliferation following chronic active Epstein‐Barr virus infection and hypersensitivity to mosquito bites , 1997, American journal of hematology.

[9]  M. Ladanyi,et al.  Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. , 1994, The New England journal of medicine.

[10]  Masahito Hayashi,et al.  Ganciclovir for chronic active Epstein-Barr virus infection , 1993, The Lancet.

[11]  A. Tawa,et al.  SUCCESSFUL TREATMENT OF CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION WITH RECOMBINANT INTERLEUKIN-2 , 1987, The Lancet.

[12]  C. Griscelli,et al.  PERSISTENT EPSTEIN-BARR VIRUS INFECTION IN A CHILD WITH HYPERGAMMAGLOBULINÆMIA AND IMMUNOBLASTIC PROLIFERATION ASSOCIATED WITH A SELECTIVE DEFECT IN IMMUNE INTERFERON SECRETION , 1978, The Lancet.

[13]  K. Kawa,et al.  Current Diagnosis and Treatment Strategy for Chronic Active Epstein-Barr Virus Infection , 2012 .

[14]  T. Gross Treatment for Epstein-Barr virus-associated PTLD. , 2009, Herpes : the journal of the IHMF.

[15]  N. Majhail Old and new cancers after hematopoietic-cell transplantation. , 2008, Hematology. American Society of Hematology. Education Program.